DeltaRex-G (retroviral expression vectors bearing inhibitory genes) / GenVivo 
Welcome,         Profile    Billing    Logout  
 19 Diseases   1 Trial   1 Trial   27 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DeltaRex-G (retroviral expression vectors bearing inhibitory genes) / GenVivo
NCT04378244: CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19

Withdrawn
1/2
18
NA
DeltaRex-G, DeltaRex-G Retroviral Vector Encoding a Cyclin G1 Inhibitor
Aveni Foundation
COVID-19, Cytokine Storm, Acute Respiratory Distress Syndrome
12/23
07/24
NCT04091295: BLESSED: Expanded Access for DeltaRex-G for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Available
N/A
US
DeltaRex-G, DeltaRex-G Retroviral Vector Encoding a Cyclin G1 Inhibitor
Aveni Foundation
Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor), Chondrosarcoma, Soft Tissue Sarcoma, Chordoma, Sarcoma, Carcinoma of Breast
 
 

Download Options